BACKGROUND: Gradient gel electrophoresis (GGE) and nuclear magnetic resonance (NMR) spectroscopy are both widely accepted methods for measuring LDL and HDL particle size. However, whether or not GGE-or NMR-measured LDL or HDL particle size predicts coronary heart disease (CHD) risk to a similar extent is currently unknown.
. Several investigations have shown that this atherogenic dyslipidemia, independently of plasma LDL cholesterol concentrations, is closely associated with other CHD risk factors that have an important pathophysiological role in the development of atherosclerosis (4, 5 ) . In many prospective studies small, dense LDL particles have been shown to be an intrinsic feature of this dyslipidemia and to increase CHD risk (6 -8 ) . Depletion of cholesteryl esters and triglyceride enrichment of LDL particles are associated with a decreased size as well as increased density of these particles, and these properties reduce their affinity for the LDL receptor (9 ) . As a consequence, small and dense LDL are likely to have an increased residence time in the circulation, making them more susceptible to oxidation or glycosylation, which considerably increases their atherogenic potential (10 ) . With regard to HDL particles, only a few studies have sought to establish a relationship between particle size and CHD risk (11) (12) (13) . It has been hypothesized that reduced HDL particle size is, similarly to small LDL particles, a consequence of the increased activity of various lipases and other enzymes that increase the triglyceride content of these particles, thereby altering the efficiency of the reverse cholesterol-transport pathway (14, 15 ) .
Polyacrylamide gradient-gel electrophoresis (GGE) and proton nuclear magnetic resonance (NMR) spectroscopy are the most commonly used methods to measure LDL and HDL size. These techniques rely on very different principles and, hence, might not discriminate CHD risk associated with LDL or HDL particle size to a similar extent. To date, only 1 crosssectional study has compared the agreement between LDL size as measured by GGE and NMR (16 ) and the results suggested that these methods are not interchangeable. However, this study did not compare NMR and GGE in terms of their ability to predict CHD risk. Also, no study has sought to compare the agreement between GGE and NMR measurement of HDL size. Consequently, the relative predictability of CHD risk associated with GGE-and NMR-measured LDL and HDL particle size is unclear.
The objectives of the present study were to compare the agreement between LDL and HDL size as measured by GGE and NMR and compare the ability of these 2 methods to predict the risk of future CHD associated with the size of LDL and HDL particles. We examined these questions in a large prospective casecontrol study performed in a European cohort representative of a contemporary Western population.
Materials and Methods

STUDY DESIGN
We performed a nested case-control analysis of participants of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study, a prospective population study of 25 663 men and women between 45 and 79 years old residing in Norfolk, UK, who completed a baseline questionnaire survey and attended a clinic visit (17 ) . Participants were recruited from age-sex registers of general practices in Norfolk as part of the 9-country collaborative EPIC study designed to investigate dietary and other determinants of cancer. Additional data were obtained in EPICNorfolk to enable the assessment of determinants of other diseases. The study cohort was quite similar to UK population samples with regard to many characteristics, including anthropometry, blood pressure, and lipids, but with a lower proportion of smokers. The design and methods of the study have been described in detail (17 ) . In short, eligible participants were recruited by mail. At the baseline survey performed between 1993 and 1997, participants completed a detailed health and lifestyle questionnaire. Blood was collected by venipuncture into plain and citrate tubes. Blood samples were processed for various assays at the Department of Clinical Biochemistry, University of Cambridge, or stored at Ϫ80°C. Nonfasting serum concentrations of total cholesterol, HDL cholesterol, and triglycerides were measured in fresh samples with the RA 1000 (Bayer Diagnostics), and LDL cholesterol concentrations were calculated with the Friedewald formula (18 ). LDL peak particle size and HDL mean particle size were measured, respectively, by 2%-16% and 4%-30% polyacrylamide GGE, as previously described (6, 19 ) . Proton NMR spectroscopy measurements were also performed to measure mean LDL and HDL particle sizes by use of a 400-MHz proton NMR analyzer at Liposcience (Raleigh, NC) as previously described (20 ) .
All individuals were flagged for mortality at the UK Office of National Statistics, with vital status ascertained for the entire cohort. Death certificates for all deceased were coded by trained nosologists according to the International Classification of Diseases (ICD) 9th revision. Death was considered to have been due to CHD if the underlying cause was coded as ICD 410 -414. These codes encompass the clinical spectrum of CHD, i.e., unstable angina, stable angina, and myocardial infarction. In addition, participants admitted to the hospital were identified by their unique National Health Service number by data linkage with ENCORE (East Norfolk Health Authority database), which identifies all hospital contacts throughout England and Wales for Norfolk residents. Participants were identified as having CHD during follow-up if they had a hospital admission and/or died with CHD as an underlying cause. The Norwich District Health Authority Ethics Committee approved the study, and all participants gave signed informed consent.
PARTICIPANTS
For the present nested case-control study, 1138 apparently healthy individuals who ultimately developed fatal or nonfatal CHD during follow-up were identified. Apparently healthy individuals were defined as study participants who did not report a history of heart attack or stroke at the baseline clinic visit. Consequently, we excluded all individuals reporting a history of heart attack or stroke at the baseline clinic visit. Control participants were apparently healthy study participants who remained free of any cardiovascular disease during follow-up. Two controls were matched to each case by sex, age (within 5 years), and date of visit (within 3 months). A total of 2237 controls were matched to cases.
STATISTICAL ANALYSES
Baseline characteristics were compared between cases and controls, taking into account the matching between them. Pearson correlations were performed to examine the relationship between LDL and HDL size with anthropometric and cardiovascular risk factors before and after adjustment for waist circumference.
Pearson correlations were also performed to examine the relationship between GGE-and NMR-measured LDL and HDL size in all participants, in men and women separately, in cases and controls separately, and in participants classified on the basis of triglyceride or HDL cholesterol tertiles. Conditional logistic regression analysis was used to calculate odds ratio (OR) and corresponding 95% CI as an estimate of the relative risk of CHD in each subgroup. ORs were adjusted for age, smoking (never, past, or current), diabetes, and systolic blood pressure and further adjusted for various parameters of the lipoprotein-lipid profile. Statistical analyses were performed with SPSS software (Version 12.0.1).
Results
A complete dataset was available for 1025 cases and 1915 controls. Cases consisted of 653 men and 372 women. Baseline characteristics of the study participants are shown in Table 1 . In both sexes, participants who eventually developed CHD were more likely to smoke and have diabetes, higher adiposity indices, and increased systolic and diastolic blood pressure. Regarding their cardiometabolic risk profile, cases had higher concentrations of total and LDL cholesterol, higher triglyceride, apolipoprotein B (apoB), and C-reactive protein while having the lowest plasma concentrations of HDL cholesterol and apoA-I. Independently from the method used to measure LDL and HDL particle size, cases had slightly lower LDL and HDL particle sizes than matched controls. Table 2 shows the associations of GGE-and NMRmeasured LDL and HDL size with the anthropometric parameters and the cardiovascular risk factors in the study participants. GGE-and NMR-measured LDL and HDL particle sizes showed the highest association with waist circumference, HDL cholesterol, triglycerides, apoB, and apoA-I. Overall, the correlation coefficients were slightly, but not significantly, higher when LDL and HDL sizes were measured by NMR. We performed additional analyses with the correlation coefficient adjusted for adiposity as indicated by waist circumference and found that, overall, adjustment for adiposity had a negligible impact on the relationship between LDL or HDL particle size (measured by either GGE or NMR spectroscopy) and other parameters of the cardiometabolic risk profile (data not shown). The mean differences between GGE-and NMRmeasured LDL particle size as well as the correlation coefficients between GGE and NMR are shown in Table 3 for all participants, men and women separately, cases and controls separately, and participants classified on the basis of triglyceride and HDL cholesterol tertiles. In every category, NMR provided values for LDL size approximately 5.0 nm lower than LDL size measured by GGE. In all participants, the correlation coefficient between the 2 methods was 0.47 (P Ͻ 0.001) for LDL size and appeared to be higher in men than in women. The correlation coefficient was weaker in participants who were characterized by either low triglyceride or high HDL cholesterol concentrations. Table 4 presents the difference between GGE-and NMRmeasured HDL particle size in participants classified in the same categories as in Table 3 . Unlike LDL particle size, HDL particle size measured with GGE and NMR showed very similar mean values across the different categories, with GGE yielding slightly higher values. The difference between GGE and NMR seemed to be greater in participants with low triglyceride or high HDL cholesterol concentrations. In contrast to what was found with LDL size, the correlation between the 2 methods was high for HDL size in all participants (r ϭ 0.78, P Ͻ 0.001). The correlation coefficients were higher in participants with either low triglyceride or high HDL cholesterol concentrations; however, these differences were not as large as those found for LDL size. We also observed that the mean difference in LDL size between GGE and NMR was highest in participants with small LDL particles, whereas the difference seemed to decrease with increasing deciles of LDL size (data not shown). In participants with small HDL particles, there was a small difference between particle sizes measured with GGE and NMR, a difference that decreased with increasing deciles of HDL size. In the highest deciles, NMR yielded higher mean values (data not shown).
LDL AND HDL LIPOPROTEIN MEASUREMENTS BY GGE AND NMR
LDL AND HDL LIPOPROTEIN SIZE AND CHD RISK
The relationships between CHD risk and LDL cholesterol, HDL cholesterol, and LDL and HDL particle sizes Table 4 . Mean differences and correlation coefficients between NMR-and GGE-measured HDL particle size. are shown in Table 5 (which considers particle size as a continuous variable) and in Table 6 (which shows the OR for future CHD in participants classified on the basis of method-specific tertiles of LDL and HDL particle size before and after adjustment for cardiovascular risk factors). Independent from the method considered, participants with small LDL particles were found to be at increased CHD risk, both in unadjusted analyses and also after adjustment for classical risk factors such as age, smoking, diabetes, increased systolic blood pressure, and LDL cholesterol. However, despite the fact that the 95% CI overlapped, the relationship between LDL size measured by NMR spectroscopy was slightly stronger than when LDL size was measured with the GGE method. Participants in the bottom HDL size tertile (small HDL particles) were found to be at increased risk before and after adjustment for classical CHD risk factors, independently from the method used to measure HDL size. However, after we adjusted for classical CHD risk factors and HDL cholesterol concentrations, we found that participants with small HDL particles as measured by both methods were not at increased risk, irrespective of the method used. Overall, although 95% CIs overlapped, NMR showed slightly stronger associations with CHD risk than GGE for both LDL and HDL particle sizes. Sex-specific analyses were performed and yielded similar results (data not shown). The relationships between LDL and HDL cholesterol and CHD risk are also shown in Tables 5 and 6 . In both cases, it appeared that the relationships between the cholesterol content of these lipoprotein subfractions and CHD risk were not influenced by the size of these particles, irrespective of how particle size was assessed.
Discussion
The main finding of this analysis of lipoprotein particle sizing performed in this prospective population study is that although GGE-and NMR-measured LDL and HDL size were modestly correlated, NMR seemed to better capture the CHD risk associated with small LDL and HDL particle size. We also found that GGE-and NMR-measured LDL and HDL sizes were associated with markers of metabolic dyslipidemia, as characterized by hypertriglyceridemia and increased waist circumference and apoB, as well as decreased HDL cholesterol and apoA-I. LDL and HDL sizes measured by NMR seemed to better correlate with these cardiometabolic abnormalities than LDL and HDL sizes measured by GGE, an observation that may explain, to a certain extent, the tendency toward better CHD risk prediction obtained with NMR spectroscopy. To date, very few studies have examined the agreement between GGE and NMR with respect to LDL and HDL particle sizes, and no study has yet investigated the ability of these techniques to predict CHD events. The most important study comparing LDL particle sizing by GGE and NMR spectroscopy was performed by Witte et al. (16 ) , who showed modest agreement in a study sample that included 324 individuals. Although the correlation between LDL size measured by both methods was slightly lower in that study compared to what we have observed, the mean difference between LDL size measured by both techniques was found to be very similar (5.4 nm vs 5.0 nm in our study). We also observed sex-specific associations similar to those described by Witte et al.; in both studies the difference in LDL size measured by GGE and NMR was higher in men than in women. Similar to that previous study, we also found that the agreement between both methods was higher in individuals with high triglyceride or low HDL cholesterol concentrations. Although the study of Witte et al. was important in showing for the first time that GGE-and NMR-measured LDL size showed modest agreement, which depended on "metabolic" conditions, this study was limited to a fairly small study sample and to LDL size only, and had a cross-sectional design.
In the present study, we obtained similar findings regarding LDL size and further extended these findings to HDL particles in a much larger study sample. Our results not only provide further evidence that GGE and NMR are not interchangeable but they also show that the difference between both methods might have different consequences in terms of cardiovascular risk prediction.
Although by GGE the within-laboratory "intergel" and "intragel" reproducibility values (CVs) for the measurement of LDL size were Ͻ2% and Ͻ1.5%, respectively (21 ) , and for HDL size were Ͻ5% and Ͻ1.5% (19 ) , the interlaboratory reproducibility is often poor because the GGE method is not well standardized. On the other hand, one limitation attributed to this method is that the assessment of LDL and HDL particle size requires a lot of time and effort, an observation likely to discourage laboratory personnel and general practitioners from measuring LDL and HDL size in their clinical practice. Moreover, although this was not the objective of the present study, the fact that most studies have shown that LDL size (independently from the method employed for its measurement) does not add to CHD risk prediction on top of currently available (and more easily obtainable) CHD risk factors is another factor which could explain the rather rare use of LDL or HDL size measurement in clinical practice (22, 23 ) . A limitation attributed to the NMR technique is the fact that the reproducibility between laboratories cannot be measured because NMR characteristics of LDL or HDL particles can be measured only at Liposcience (http://www.liposcience.com), which currently does not provide the instrumentation for the method to clinical laboratories. Therefore, the routine measurement of NMR characteristics of lipoproteins is far from being incorporated in daily clinical practice. However, interassay and intraassay reproducibility is higher for NMR spectroscopy than for GGE (NMR intraassay CV 0.5% for both LDL and HDL sizes, interassay CVs 0.4% and 0.6%, respectively, for LDL and HDL size). Based on these results, it is not clear whether the reason for the stronger association of NMR-measured lipoprotein size with CHD risk is because it provides a better association with cardiometabolic risk, because the measurement of lipoprotein particle size by NMR is more accurate, or because NMR spectroscopy is more precise (as judged by the lower intraassay and interassay CVs). The latter theory cannot be tested because there is no gold-standard method for the measurement of lipoprotein size. For the moment, it would be speculative to suggest solely based on our observations that NMR provides a better measurement of lipoprotein size than GGE. However, studies comparing LDL and HDL particle sizes as assessed by GGE and NMR spectroscopy and electron microscopy would be very useful to test which of these methods provides a more accurate assessment of LDL and HDL particle sizes. In contrast to the 5-nm difference between NMR-measured and GGE-measured LDL size, our study shows that GGE and NMR spectroscopy yield mean HDL size values that are in a very similar range. Previous studies have shown that NMR spectroscopy and GGE yield different mean values for LDL size (16, 24, 25 ) . This difference is somewhat difficult to interpret, although it may be attributable to the charge of the particle, which increases proportionally to particle size and is likely to impact LDL size measured with GGE, but not NMR. This finding could also be attributable to the fact that NMR works under the assumption that LDL particles are spherical, whereas it has been suggested that LDL particles may have a discoidal rather than a spherical shape.
Certain aspects of this study merit further consideration. First, the electrophoretic and NMR characteristics of LDL and HDL particles were determined in nonfasting samples. The fact that these samples were collected at different periods during the day could influence plasma triglyceride concentrations. Because triglyceride concentrations are the best correlate of LDL particle physicochemical characteristics, these characteristics of the study samples may have had an impact on LDL properties, although we (26 ) and others (27 ) have shown that postprandial lipemia does not have a strong effect on LDL particle size. Because GGE and NMR spectroscopy rely on 2 different principles, it is also possible that the fasting state might impact NMR-and GGE-measured lipoprotein size differently, or to a different extent. The use of nonfasting samples might also have influenced LDL cholesterol concentrations, because the calculation of LDL cholesterol by the Friedewald formula relies on fasting triglycerides. Second, GGE and NMR were performed with samples that had been kept at Ϫ80°C for several years. However, these limitations would introduce an increased random measurement error, which is likely to lead to an underestimation of any relationship between lipoprotein characteristics and CHD risk. In addition, the majority of study participants were somewhat advanced in age at study baseline, which could have introduced a survival bias. Similar analyses will have to be performed in younger populations and other ethnic groups to confirm and/or extend our observations. Finally, emerging techniques have been proposed to measure LDL and HDL particle sizes, such as HPLC (28 ) and microfluid gel electrophoresis, which was used in the PROCAM (Prospective Cardiovascular Münster) study (29 ) . The ability to predict CHD risk associated with either small LDL or HDL particles as measured by these methods remains to be established.
In conclusion, our study results suggest that the overall agreement between NMR and GGE for the measurement of LDL size is modest and is better for HDL size. This study also suggests that NMR might provide a better CHD risk estimation associated with the small LDL and HDL phenotype than GGE. 
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